НовостиBenzingaPiper Sandler Maintains Overweight on Bioage Labs, Lowers Price Target to $40 Piper Sandler Maintains Overweight on Bioage Labs, Lowers Price Target to $40 Benzinga 2026.11.09 17:09 (GMT+0) Открыть на Benzinga Другие новости